Literature DB >> 4039134

Human tissue-type plasminogen activator. Production in continuous serum-free cell culture and rapid purification.

E K Kruithof, W D Schleuning, F Bachmann.   

Abstract

A simplified procedure for the production and purification of human tissue-type plasminogen activator (t-PA) is described. Bowes-melanoma cells were maintained in continuous serum-free culture. The cell nutrient consisted of Dulbecco's modified Eagle's medium (DMEM) supplemented with insulin (5 mg/litre), transferrin (5 mg/litre), progesterone (1 nM), cortisol (10 nM), aprotinin (2 X 10(4) units/litre) and a mixture of trace elements. t-PA accumulated in the culture medium at a rate of 40 units/day per ml and was harvested every third day. Cell losses during each harvest, leading to a steady decline of enzyme yields, were compensated for by treating the cells with 5% (v/v) fetal-bovine serum in DMEM every 6-8 weeks. t-PA was rapidly purified by a combination of cation-exchange chromatography and gel filtration. The procedure yielded mainly single-chain t-PA of a specific activity of 80 000 to 100 000 units/mg.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039134      PMCID: PMC1144759          DOI: 10.1042/bj2260631

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  21 in total

1.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding.

Authors:  M M Bradford
Journal:  Anal Biochem       Date:  1976-05-07       Impact factor: 3.365

2.  Growth and maintenance of HeLa cells in serum-free medium supplemented with hormones.

Authors:  S E Hutchings; G H Sato
Journal:  Proc Natl Acad Sci U S A       Date:  1978-02       Impact factor: 11.205

3.  Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

Authors:  H Towbin; T Staehelin; J Gordon
Journal:  Proc Natl Acad Sci U S A       Date:  1979-09       Impact factor: 11.205

4.  The growth of mouse melanoma cells in hormone-supplemented, serum-free medium.

Authors:  J P Mather; G H Sato
Journal:  Exp Cell Res       Date:  1979-04       Impact factor: 3.905

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Specific lysis of an iliofemoral thrombus by administration of extrinsic (tissue-type) plasminogen activator.

Authors:  W Weimar; J Stibbe; A J van Seyen; A Billiau; P De Somer; D Collen
Journal:  Lancet       Date:  1981-11-07       Impact factor: 79.321

7.  Thrombolysis by human tissue plasminogen activator and urokinase in rabbits with experimental pulmonary embolus.

Authors:  O Matsuo; D C Rijken; D Collen
Journal:  Nature       Date:  1981-06-18       Impact factor: 49.962

8.  Purification and characterization of the plasminogen activator secreted by human melanoma cells in culture.

Authors:  D C Rijken; D Collen
Journal:  J Biol Chem       Date:  1981-07-10       Impact factor: 5.157

9.  A study of proteases and protease-inhibitor complexes in biological fluids.

Authors:  A Granelli-Piperno; E Reich
Journal:  J Exp Med       Date:  1978-07-01       Impact factor: 14.307

10.  Properties of plasminogen activators formed by neoplastic human cell cultures.

Authors:  D B Rifkin; J N Loeb; G Moore; E Reich
Journal:  J Exp Med       Date:  1974-05-01       Impact factor: 14.307

View more
  6 in total

1.  Induction of urokinase activity and malignant phenotype in bladder carcinoma cells after transfection of the activated Ha-ras oncogene.

Authors:  G Brunner; J Pohl; L J Erkell; A Radler-Pohl; V Schirrmacher
Journal:  J Cancer Res Clin Oncol       Date:  1989       Impact factor: 4.553

Review 2.  Tissue-type plasminogen activator. A review of its pharmacology and therapeutic use as a thrombolytic agent.

Authors:  D Collen; H R Lijnen; P A Todd; K L Goa
Journal:  Drugs       Date:  1989-09       Impact factor: 9.546

3.  Plasminogen activator inhibitor activity and other fibrinolytic variables in patients with coronary artery disease.

Authors:  J Aznar; A Estellés; G Tormo; P Sapena; V Tormo; S Blanch; F España
Journal:  Br Heart J       Date:  1988-05

4.  Two-dimensional electrophoresis as a tool for control of quality and consistency in production systems using animal cells. Two-dimensional electrophoresis in animal cell culture technology.

Authors:  H Harant; K Wimmer; E Wenisch; K Strutzenberger; M Reiter; G Blüml; T Gaida; C Schmatz; H Katinger
Journal:  Cytotechnology       Date:  1992       Impact factor: 2.058

5.  Active site labeling with dansyl-glutamyl-glycyl-arginyl chloromethyl ketone demonstrates the full activity of the refolded and purified tissue-type plasminogen activator variant BM 06.022.

Authors:  U Kohnert; M Wozny; M Llinas; A Roos; S Fischer
Journal:  Appl Biochem Biotechnol       Date:  1995-11       Impact factor: 2.926

6.  Helodermatine, a kallikrein-like, hypotensive enzyme from the venom of Heloderma horridum horridum (Mexican beaded lizard).

Authors:  A Alagon; L D Possani; J Smart; W D Schleuning
Journal:  J Exp Med       Date:  1986-12-01       Impact factor: 14.307

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.